Share This Page
Suppliers and packagers for CLEOCIN T
✉ Email this page to a colleague
CLEOCIN T
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CLEOCIN T | clindamycin phosphate | GEL;TOPICAL | 050615 | NDA AUTHORIZED GENERIC | Mylan Pharmaceuticals Inc. | 59762-3743-1 | 1 TUBE in 1 CARTON (59762-3743-1) / 30 g in 1 TUBE | 1987-01-07 |
| Pfizer | CLEOCIN T | clindamycin phosphate | GEL;TOPICAL | 050615 | NDA AUTHORIZED GENERIC | Mylan Pharmaceuticals Inc. | 59762-3743-2 | 1 TUBE in 1 CARTON (59762-3743-2) / 60 g in 1 TUBE | 1987-01-07 |
| Pfizer | CLEOCIN T | clindamycin phosphate | LOTION;TOPICAL | 050600 | NDA | Pharmacia & Upjohn Company LLC | 0009-3329-01 | 1 BOTTLE in 1 CARTON (0009-3329-01) / 60 mL in 1 BOTTLE | 1989-05-31 |
| Pfizer | CLEOCIN T | clindamycin phosphate | LOTION;TOPICAL | 050600 | NDA AUTHORIZED GENERIC | Mylan Pharmaceuticals Inc. | 59762-3744-1 | 1 BOTTLE in 1 CARTON (59762-3744-1) / 60 mL in 1 BOTTLE | 1989-05-31 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: CLEOCIN T
Introduction
CLEOCIN T is a well-established topical antibiotic, primarily used for the treatment of bacterial skin infections caused by susceptible strains of certain microorganisms. Its active compound, clindamycin phosphate, belongs to the lincosamide class of antibiotics. Given its widespread clinical application, a robust supply network for CLEOCIN T is pivotal for healthcare providers and pharmaceutical distributors to ensure uninterrupted patient access. This article delves into the key suppliers, manufacturing landscape, distribution channels, and strategic considerations related to CLEOCIN T supply.
Overview of CLEOCIN T and Its Market
CLEOCIN T’s formulation as clindamycin phosphate topical solution has garnered broad acceptance due to its efficacy against acne, impetigo, and other localized infections. The global demand for such topical antibiotics has been steady, driven by the prevalence of skin infections and increasing antibiotic resistance trends that favor targeted therapies.
Manufacturers typically synthesize CLEOCIN T via chemical processes involving the production of high-purity clindamycin phosphate. The supply chain involves active pharmaceutical ingredient (API) producers, formulation experts, and final product packagers. These companies often operate across North America, Europe, and Asia, where the bulk of pharmaceutical manufacturing resides.
Major Suppliers and Manufacturers
1. Pharmacia & Upjohn / Pfizer
- Overview: Pfizer, through its acquisition of Pharmacia & Upjohn, historically has been a principal producer of clindamycin phosphate. The company's extensive R&D capabilities and global manufacturing footprint facilitate reliable supply chains.
- Supply Role: Pfizer supplies both APIs and finished formulations of CLEOCIN T to markets worldwide.
- Note: Due to patent expirations and generic competition, Pfizer's dominance has decreased, but its capacity remains significant.
2. Sun Pharmaceutical Industries Ltd.
- Overview: As one of India's largest generic pharmaceutical companies, Sun Pharma produces and supplies clindamycin phosphate APIs and formulations.
- Supply Role: Sun Pharma manufactures both API and finished topical formulations, exporting globally, particularly to underserved markets.
- Strategic Position: Its robust manufacturing facilities and cost-effective production make it a key supplier for generic CLEOCIN T.
3. Mylan N.V. / Viatris
- Overview: Mylan, now part of Viatris, is a dominant supplier of generic antibiotics, including clindamycin phosphate.
- Supply Role: Provides APIs and finished products to various regions, including North America and Europe.
- Note: Its vast distribution channels ensure quick and reliable supply of CLEOCIN T.
4. Sandoz (Novartis)
- Overview: Sandoz is a global leader in generic pharmaceuticals and biosimilars.
- Supply Role: Manufactures clindamycin phosphate API and formulations, primarily targeting European markets.
- Quality Assurance: Known for strict quality standards aligned with international GMP guidelines.
5. Local and Regional Suppliers
- Numerous regional manufacturers operate under GMP compliances in Asia and Europe, supplying not only generic clindamycin phosphate but also custom formulations conforming to regional regulations.
- Countries such as India, China, and Eastern European nations host several such manufacturers, often serving local markets or acting as contract manufacturers.
Supply Chain Dynamics
API Production
The backbone of CLEOCIN T supply hinges on the availability of high-quality APIs. Key considerations include:
- GMP Compliance: Manufacturers must adhere to strict Good Manufacturing Practices (GMP) to ensure safety, potency, and consistency.
- Raw Material Sourcing: API producers rely on raw materials sourced globally, which introduces vulnerability to supply chain disruptions.
- Regulatory Approvals: API suppliers must have regulatory approvals from agencies such as the FDA, EMA, and other national authorities.
Formulation and Final Product Manufacturing
Post-API production, the formulation stage involves compounding the API into topical solutions, adhering to regional packaging standards and stability requirements. Partnering with reputable contract manufacturing organizations (CMOs) enhances supply reliability.
Distribution Channels
Distribution networks often include wholesale distributors, pharmacy chains, hospitals, and regional drug retailers. Large pharmaceutical companies and generic manufacturers maintain extensive distribution agreements to ensure timely delivery. Import/export regulations significantly influence regional availability.
Strategic Sourcing and Risk Management
-
Diversification of Suppliers: Companies often diversify sources — engaging multiple API manufacturers across geographies to mitigate risks related to geopolitical tensions, natural disasters, or manufacturing setbacks.
-
Supply Agreements: Long-term contractual agreements with key suppliers ensure priority access during global shortages.
-
Regulatory Alignment: Maintaining compliance with evolving international standards mitigates delays in registration or import licenses.
-
Inventory Management: Establishing safety stock levels and alternative supply chains minimizes out-of-stock scenarios.
Emerging Trends Affecting Supply
-
Generic Market Expansion: The expiration of patents has fostered proliferation of generic CLEOCIN T, leading to increased supplier competition and potentially lower pricing.
-
Supply Chain Disruptions: Global events, such as the COVID-19 pandemic, highlighted vulnerabilities in the supply chain, prompting manufacturers to reassess sourcing strategies.
-
Regulatory Harmonization: Efforts to streamline approval processes across regions may facilitate quicker market entry for new suppliers, enhancing supply security.
Conclusion: Ensuring a Stable Supply of CLEOCIN T
A resilient supply of CLEOCIN T hinges on diversified sourcing, strict adherence to quality standards, and adaptive supply chain strategies. Major global players like Pfizer, Sun Pharma, Mylan/Viatris, and Sandoz maintain significant stakes, complemented by regional manufacturers. Stakeholders must monitor regulatory shifts and geopolitical risks to sustain uninterrupted availability of this critical antibiotic formulation.
Key Takeaways
- Diverse Supplier Base: The global landscape includes major international manufacturers and regional players, reducing dependency risks.
- API and Formulation Quality: Ensuring compliance with GMP and maintaining regulatory approvals is crucial for supply continuity.
- Supply Chain Resilience: Diversification, strategic partnerships, and inventory management mitigate disruptions.
- Regulatory and Market Dynamics: Patent expirations and generics proliferation intensify competition but require careful quality oversight.
- Emerging Risks and Opportunities: Evolving geopolitical and health crises emphasize the need for adaptive supply chain strategies.
FAQs
1. Who are the main global suppliers of CLEOCIN T?
Major suppliers include Pfizer (historically), Sun Pharmaceutical, Mylan (Viatris), and Sandoz, along with numerous regional manufacturers in Asia and Europe.
2. Are there regional differences in CLEOCIN T supply?
Yes. While global players dominate big markets, regional manufacturers often supply local or emerging markets, with variations in quality standards and regulatory approvals.
3. What risks affect the supply of CLEOCIN T?
Risks include raw material shortages, manufacturing issues, regulatory delays, geopolitical tensions, and global health crises impacting supply chains.
4. How do patent expirations influence CLEOCIN T supply?
Patent expirations foster generic competition, increasing supplier options, potentially leading to price reductions but also necessitating rigorous quality assurance.
5. How can healthcare providers ensure continuous access to CLEOCIN T?
By establishing diversified supplier relationships, maintaining safety stocks, and monitoring regulatory and geopolitical developments that could impact supply.
Sources:
[1] Pharmaceutical Industry Reports; [2] WHO Drug Information; [3] FDA and EMA Regulatory Guidelines; [4] Company Annual Reports; [5] Market Intelligence Platforms.
More… ↓
